Spinraza 12mg/5ml

Spinraza 12mg/5ml is a medicine authorised by Swissmedic under authorisation number 66495. The authorisation holder is Biogen Switzerland AG. The medicinal product code is Transplant: gene therapy product and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 20 September 2017 and the authorisation is valid without a time limit. ATC code M09AX places the medicine in the group Other drugs for disorders of the musculo-skeletal system.

  • Dispensing category A
  • Authorisation number 66495
  • ATC M09AX
  • Transplant: gene therapy product
Authorisation data
Authorisation number66495
NameSpinraza 12mg/5ml
Full nameSpinraza 12mg/5ml, Injektionslösung zur intrathekalen Injektion
Authorisation holderBiogen Switzerland AG
Medicinal product codeTransplant: gene therapy product
Dispensing categoryA · Prescription, not repeatable
ATC codeM09AX
First authorisation20 September 2017
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Spinraza 12mg/5ml, Injektionslösung zur intrathekalen InjektionA20 September 2017
2Spinraza 28mg/5ml, Injektionslösung zur intrathekalen InjektionA19 February 2026
3Spinraza 50mg/5ml, Injektionslösung zur intrathekalen InjektionA19 February 2026

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
15 mlDurchstechflasche(n)M09AX01.99.0.A
25 mlDurchstechflasche(n)M09AX01.99.0.A
35 mlDurchstechflasche(n)M09AX01.99.0.A

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Spinraza 12mg/5ml authorised in Switzerland?

Yes. Spinraza 12mg/5ml is authorised by Swissmedic under authorisation number 66495, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Spinraza 12mg/5ml have?

Spinraza 12mg/5ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Spinraza 12mg/5ml?

The authorisation holder is Biogen Switzerland AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com